Showing results (151-160 of 335) with videos related to

Sort By:
Pageof 34
Translational Lung Cancer Research|February 11, 2021
Prognostic factors in older patients with wild-type epidermal growth factor receptor advanced non-small cell lung cancer: a multicenter retrospective studyYurie Seto, Yoshiko Kaneko, Takako Mouri, et al.
The Oncologist|May 10, 2020
Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801Koichi Takayama, Masafumi Takeshita, Koji Inoue, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
A phase II trial of gefitinib monotherapy in chemotherapy-naïve patients of 75 years or older with advanced non-small cell lung cancerNoriyuki Ebi, Hiroshi Semba, Sho J I Tokunaga, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 27, 2012
Efficacy of aprepitant in patients with advanced or recurrent lung cancer receiving moderately emetogenic chemotherapyJunji Uchino, Ryosuke Hirano, Naoki Tashiro, et al.
Internal Medicine (Tokyo, Japan)|July 3, 2020
The Quality of Life of Patients with Suspected Lung Cancer before and after Bronchoscopy and the Effect of Mirtazapine on the Depressive StatusYoshiko Kaneko, Takako Mouri, Yurie Seto, et al.
Anticancer Research|March 31, 2018
Feasibility Study of Sequentially Alternating EGFR-TKIs and Chemotherapy for Patients with Non-small Cell Lung CancerYoshizumi Takemura, Yusuke Chihara, Yoshie Morimoto, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line AlectinibTakayuki Takeda, Tadaaki Yamada, Keiko Tanimura, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 24, 2016
Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trialKoichi Takayama, Nobuyuki Katakami, Takuma Yokoyama, et al.
International Immunopharmacology|April 18, 2022
A real-world study on the safety of the extended dosing schedule for nivolumab and pembrolizumab in patients with solid tumorsKenji Morimoto, Tadaaki Yamada, Yoshie Morimoto, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2025
Prevalence and molecular landscape of NRG1 fusions in Japanese solid tumors: a nationwide data analysis using the C-CAT databaseMasaki Ishida, Tadaaki Yamada, Ryo Tsunashima, et al.
Pageof 34